pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
MIIST-305
Gastrointestinal Radiation Toxicity
Synedgen Inc
MILRINONE LACTATE IN 5% DEXTROSE
MILRINONE LACTATE IN 5% DEXTROSE
no indication
CAPLIN
MILRINONE LACTATE IN DEXTROSE
MILRINONE LACTATE IN DEXTROSE
no indication
HIKMA FARMACEUTICA
MINOXIDIL TOPICAL SOLUTION, 5%
MINOXIDIL TOPICAL SOLUTION, 5% (MINOXIDIL SOLUTION)
← prev
page 124 of 271
next →
Pain
89
Neurology
1
no indication
TARO
MINZOYA
MINZOYA (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS BISGLYCINATE)
no indication
Lupin Ltd
Preclinical
MIRA-55
Anxiety Disorders
$MIRA
MIRA PHARMACEUTICALS, INC.
MIRABEGRON
MIRABEGRON
no indication
Lupin Ltd
Marketed
MIRTAZAPINE
MIRTAZAPINE
Major Depressive Disorder
Annora Pharma Pvt Ltd
Phase 2
MIT-001
Oral Mucositis
MitoImmune Therapeutics Inc
MITOXANTRONE
MITOXANTRONE
no indication
HOSPIRA
Phase 2
MIV-711
Osteoarthritis
Medivir AB
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE)
no indication
SpecGx LLC
Phase 3
MK-1406
Pandemic Influenza
$MRK
Merck & Co., Inc.
Phase 2
MK-2214
Alzheimer's Disease
$MRK
Merck & Co., Inc.
Phase 2
MK-3795
Von Hippel-Lindau Syndrome
$MRK
Merck & Co., Inc.
Phase 2
MK-6194
Ulcerative Colitis
$MRK
Merck & Co., Inc.
Marketed
ML-061
Docivyx (docetaxel)
Adenocarcinoma Of The Gastroesophageal Junction
Meridian Laboratories Inc
Preclinical
MLN-33
Melanoma
$CNBX
CNBX Pharmaceuticals Inc.
Phase 2
MNV-101
Pearson Syndrome
Minovia Therapeutics Ltd
Phase 2
MNV-201
Pearson Syndrome
Minovia Therapeutics Ltd
Phase 1
MO-03
Metastatic Renal Cell Carcinoma
Osel Inc
Phase 1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
Preclinical
MOMA-989
Unspecified Cancer
Moma Therapeutics Inc
MOMETASONE FUROATE MONOHYDRATE
MOMETASONE FUROATE MONOHYDRATE
no indication
AUROBINDO PHARMA
MONTELUKAST
MONTELUKAST
no indication
MACLEODS PHARMS LTD
Phase 2
MORF-057
Crohn's Disease (Regional Enteritis)
Eli Lilly and Co
Marketed
MORPHINE SULFATE
MORPHINE SULFATE
Pain
Piramal Critical Care Inc
MOUNJARO
MOUNJARO (TIRZEPATIDE)
1 INDICATIONS AND USAGE MOUNJARO ® is indicated as an adj…
$LLY
ELI LILLY & Co
MOXIFLOXACIN OPHTHALMIC SOLUTION
MOXIFLOXACIN OPHTHALMIC SOLUTION
no indication
ALEMBIC
Preclinical
MP-004
Retinitis Pigmentosa (Retinitis)
MIRAMOON Pharma SL
